The Enterprise Value as of September 2024 (TTM) for Foghorn Therapeutics Inc. (FHTX) is 414.31M

According to Foghorn Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 414.31M. This represents a change of 85.42% compared to the average of 223.45M of the last 4 quarters.

Foghorn Therapeutics Inc. (FHTX) Historical Enterprise Value (quarterly & annually)

How has FHTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Foghorn Therapeutics Inc. over the last ten years is 456.72M. The current 414.31M Enterprise Value has changed 8.97% with respect to the historical average. Over the past ten years (40 quarters), FHTX's Enterprise Value was at its highest in in the December 2021 quarter at 802.74M. The Enterprise Value was at its lowest in in the December 2022 quarter at -27585078.32.

Foghorn Therapeutics Inc. (FHTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Foghorn Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Foghorn Therapeutics Inc. (FHTX) Average Enterprise Value

How has FHTX Enterprise Value performed in the past?

The current Enterprise Value of Foghorn Therapeutics Inc. (FHTX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Foghorn Therapeutics Inc. (FHTX) Enterprise Value vs. Peers

How is FHTX’s Enterprise Value compared to its peers?

Foghorn Therapeutics Inc.’s Enterprise Value is less than C4 Therapeutics, Inc. (433.17M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Prelude Therapeutics Incorporated (133.44M), greater than Rezolute, Inc. (282.08M), greater than Shattuck Labs, Inc. (119.24M), greater than Monte Rosa Therapeutics, Inc. (284.72M), less than Kymera Therapeutics, Inc. (3.12B), less than Nurix Therapeutics, Inc. (1.55B), greater than Molecular Partners AG (-9781239.81), greater than MediciNova, Inc. (45.91M), greater than Anebulo Pharmaceuticals, Inc. (49.05M), greater than Champions Oncology, Inc. (72.61M), greater than PMV Pharmaceuticals, Inc. (41.69M), less than Stoke Therapeutics, Inc. (583.04M), greater than Century Therapeutics, Inc. (149.62M), less than Edgewise Therapeutics, Inc. (1.54B), less than Mineralys Therapeutics, Inc. (509.22M), less than Cullinan Oncology, Inc. (865.20M),

Build a custom stock screener for Foghorn Therapeutics Inc. (FHTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Foghorn Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Foghorn Therapeutics Inc. (FHTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Foghorn Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.